Biotech entity
Every one of those 1 sits in a single category, funding. Sift Biosciences is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 3 original sources each against 2.4 for the same window.
Last mentioned: Feb 19, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, funding. Sift Biosciences is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 3 original sources each against 2.4 for the same window. The average consequence score is 6, matching the 6 beat baseline for this window. Lifespan Vision Ventures appears in 1 tracked Biotech story from February 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 27 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Lifespan Vision Ventures. Shared-story counts are live from our verified record — not editorial picks.
Sift Biosciences has secured $3.7 million in a pre-seed financing round co-led by Lifespan Vision Ventures to advance its innovative technology platform. The investment underscores a growing trend of early-stage capital flowing into biotech startups focused on longevity and age-related diseases.
Source: citybiz · Newswire Canada
Lifespan Vision Ventures is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
